NWK Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-95
Closed -$15K – 119
2021
Q1
$15K Hold
95
– – 0.01% 153
2020
Q4
$12K Hold
95
– – 0.01% 156
2020
Q3
$11K Hold
95
– – 0.01% 147
2020
Q2
$8K Hold
95
– – ﹤0.01% 189
2020
Q1
$7K Buy
95
+55
+138% +$4.22K 0.01% 145
2019
Q4
$3K Buy
+40
New +$2.88K ﹤0.01% 181

Other funds holding GH

NWK Group's GH Position: Q2 2021 in Review

NWK Group sold out of Guardant Health (GH) in Q2 2021, closing a stake of 95 shares — an estimated $15K sold.

NWK Group first reported a position in GH in Q4 2019 and held it in 6 quarters. The position peaked at $15K in Q1 2021. 417 funds tracked by Wall St. Rank hold GH as of Q2 2021.

  • NWK Group reported no remaining Guardant Health position as of Q2 2021 after selling out during the quarter.
  • NWK Group sold 95 Guardant Health shares in Q2 2021, an estimated $15K.
  • NWK Group first reported a position in Guardant Health in Q4 2019 and held it in 6 quarters.
  • NWK Group's Guardant Health position peaked at $15K in Q1 2021.
  • 417 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on NWK Group's 13F filing for Q2 2021, filed 16 Aug 2021.